Earnings from Fiserv, Silgan and Thermo

We had three more Buy List earnings reports this morning.

Let’s start with Fiserv (FISV). For Q3, the company earned $1.47 per share. That beat the Street by two cents per share. Fiserv now expects 2021 revenue growth of 11% and EPS between $5.55 and $5.60. That’s an increase of five cents to the lower end.

Fiserv’s new range implies Q4 earnings of $1.54 to $1.59 per share. Wall Street had been expecting $1.58 per share.

Traders aren’t pleased with these results. The stock has been down as much as 10% this morning.

Silgan Holdings (SLGN) reported Q3 earnings of $1.02 per share which was two cents below estimates. Net sales for the third quarter rose 10.9% to $1.65 billion. The increase “was the result of higher net sales in all segments.”

Silgan lowered the upper end of its full-year guidance by five cents per share. The new range is $3.30 to $3.40 per share. That implies Q4 earnings of 69 to 79 cents per share. Wall Street had been expecting 74 cents per share.

Shares of Silgan are up slightly this morning.

Thermo Fisher Scientific (TMO) said it made $5.76 per share for Q3. That easily beat Wall Street’s estimate of $4.67 per share.

Q3 revenue increased by 9% to $9.33 billion. Of that, COVID-19 response revenue was $2.05 billion. Thermo’s adjusted operating margin was 29.8%, compared with 32.9% in the third quarter of 2020.

Thermo is increasing its full-year revenue guidance by $1.2 billion to $37.1 billion. That’s revenue growth of 15%. The company is also raising its EPS guidance by $1.30 to $23.37. That’s growth of 20% over last year.

AFLAC (AFL) will be reporting after today’s close.

Posted by on October 27th, 2021 at 10:41 am


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.